New study shows Monaghan Medical’s drug-free Aerobika® device reduces acute drug usage and costs following COPD exacerbations

Real-world study presented at CHEST 2016 Annual Meeting in Los Angeles SYRACUSE, NY, October 27, 2016 – Monaghan Medical Corporation (MMC) today announced that a new study presented to the American College of Chest Physicians (CHEST) shows MMC’s Aerobika® device is effective in reducing drug use for treatment of Chronic Obstructive Pulmonary Disease (COPD). COPD is a major source of morbidity and mortality in the United States. The Center for Read Post >>